FATE Next Earnings Date Notes

— Fate Therapeutics (NASDAQ: FATE) is a clinical-stage biopharmaceutical company focused on developing off-the-shelf, cell-based immunotherapies for cancer and immune disorders using its proprietary induced pluripotent stem cell (iPSC) platform. The company's pipeline includes both natural killer (NK) cell and T-cell product candidates designed for allogeneic use, with several in early-to-mid stage clinical trials targeting hematologic malignancies & solid tumors. When listening to the next FATE earnings call, investors should pay close attention to updates on clinical trial progress & data readouts, especially for FT516, FT576, and FT819, as successful milestones here will be key indicators for future growth. Other vital metrics include pipeline expansion, strategic partnerships, cash burn rate, and current cash runway, given the company's multi-candidate development focus & absence of commercialized products. Additionally, insights into regulatory feedback, manufacturing scale-up, and upcoming catalysts such as trial initiations or enrollment completions can help investors assess FATE's ability to advance its innovative therapies & maintain financial stability as it moves toward potential commercialization. The next projected earnings date for FATE is 5/12/2026 after close (stay tuned for a confirmed earnings date once announced).

FATE Next Earnings Date FAQ

On this page we presented the FATE Next Earnings Date information for Fate Therapeutics along with recent past earnings dates. For Q4 of 2025, FATE reported earnings of -0.270/share, with the earnings report taking place on 2/26/2026. For Q3 of 2025, FATE reported earnings of -0.270/share, with the earnings report taking place on 11/13/2025. For Q2 of 2025, FATE reported earnings of -0.290/share, with the earnings report taking place on 8/12/2025. For Q1 of 2025, FATE reported earnings of -0.320/share, with the earnings report taking place on 5/13/2025. For Q4 of 2024, FATE reported earnings of -0.440/share, with the earnings report taking place on 3/5/2025. Based on these past earnings dates, the projected next earnings date for FATE is 5/12/2026 after market close.

Any self directed investor who desires to keep tabs on the companies they own, can benefit from maintaining a calendar of next earnings dates for each stock in their porfolio, such as Fate Therapeutics. When a company files its 10Q's with the SEC a mere four times a year, that certainly puts a lot of pressure on those four out of three hundred sixty five days! To say that earnings reports are important to Fate Therapeutics shareholders would thus be an understatement! That's why we started the NextEarningsDate.com website, to make it easy for self directed investors to research Fate Therapeutics next earnings dates as well as any other stock out there in our coverage universe, to see when the next FATE earnings date — or any other stock — falls on the calendar. But we also present considerably more than just the next earnings date information alone, so we encourage you to explore the additional pages linked above to look up FATE's past earnings as well, with pages for revenue and earnings history data, as well as earnings surprises as well. Thanks for visiting, and we hope you'll think of our site the next time you need to learn about the FATE next earnings date.